Close Menu
November 23, 2020
Sponsored by
Inivata

Liquid Biopsy to Understand Resistance Mechanisms in Non-Small Cell Lung Cancer

Genome Webinar

Department of Medical Oncology, Hospital Clinic,
Laboratory of Translational Genomic and Targeted Therapies in Solid Tumors, IDIBAPS; Barcelona, Spain

In non-small cell lung cancer (NSCLC), liquid biopsy allows detection of driver mutations and can shed light on the development of resistance mutations during treatment. 

This webinar will provide an overview of several studies that used a NSCLC liquid biopsy test, InVisionFirst-Lung. The assay enabled the analysis of markers present at the beginning of treatment and at progression, providing valuable insights into resistance to ALK/ROS1 and BRAF targeted agents.

Sponsored by